These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26101555)

  • 21. Painless Acanthamoeba Keratitis with Normal Vision.
    Kwok PW; Kam KW; Jhanji V; Young AL
    Optom Vis Sci; 2017 Mar; 94(3):432-435. PubMed ID: 27870779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a New Matrix Therapy Agent in Persistent Epithelial Defects After Bacterial Keratitis Treated With Topical Fortified Antibiotics.
    Chappelet MA; Bernheim D; Chiquet C; Aptel F
    Cornea; 2017 Sep; 36(9):1061-1068. PubMed ID: 28691943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A corneal ring ulcer.
    Alhajraf K; Lin SR; Jacobs DS
    Am J Ophthalmol Case Rep; 2020 Dec; 20():100856. PubMed ID: 32875150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unilateral Painful Red Eye with Corneal Cysts Assessed with Corneal Confocal Microscopy: A Case Mimicking
    Dogan AS; Gurdal C; Kabatas EU; Kabatas N; Celikay O
    Beyoglu Eye J; 2020; 5(3):234-237. PubMed ID: 35098095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acanthamoeba infection as a cause of severe keratitis in a soft contact lens wearer in Jamaica.
    Wynter-Allison Z; Lorenzo Morales J; Calder D; Radlein K; Ortega-Rivas A; Lindo JF
    Am J Trop Med Hyg; 2005 Jul; 73(1):92-4. PubMed ID: 16014841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix Regeneration Therapy: A Case Series of Corneal Neurotrophic Ulcers.
    Arvola RP; Robciuc A; Holopainen JM
    Cornea; 2016 Apr; 35(4):451-5. PubMed ID: 26845313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Management of herpes zoster neurotrophic ulcer using a new matrix therapy agent (RGTA): A case report].
    De Monchy I; Labbé A; Pogorzalek N; Gendron G; M'Garrech M; Kaswin G; Labetoulle M
    J Fr Ophtalmol; 2012 Mar; 35(3):187.e1-6. PubMed ID: 22015067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fast and sustained healing of resistant corneal ulcers using corneal scrubbing and matrix regenerating therapy.
    Lazreg S; Labetoulle M; Renault D; Baudouin C
    Eur J Ophthalmol; 2021 May; 31(3):959-966. PubMed ID: 32345041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ocular surface chemical injury treated by regenerating agent (RGTA, Cacicol20).
    Ustaoglu M; Solmaz N; Onder F
    GMS Ophthalmol Cases; 2017; 7():Doc28. PubMed ID: 29082123
    [No Abstract]   [Full Text] [Related]  

  • 30. A case of descemet's membrane rupture in a patient affected by Acanthamoeba Keratitis.
    Guerriero S; La Tegola MG; Monno R; Apruzzese M; Cantatore A
    Eye Contact Lens; 2009 Nov; 35(6):338-40. PubMed ID: 19726997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo confocal microscopy and in vitro culture techniques as tools for evaluation of severe Acanthamoeba keratitis incidents.
    Padzik M; Szaflik JP; Baltaza W; Perkowski K; Dybicz M; Chomicz L
    Ann Parasitol; 2017; 63(4):341-346. PubMed ID: 29420872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prolonged topical natamycin 5 % therapy before and after keratoplasty for Fusarium keratitis].
    Cvetkova N; Köstler J; Prahs P; Helbig H; Dietrich-Ntoukas T
    Ophthalmologe; 2016 May; 113(5):420-4. PubMed ID: 26205744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contact lens-related acanthamoeba keratitis.
    Stapleton F; Ozkan J; Jalbert I; Holden BA; Petsoglou C; McClellan K
    Optom Vis Sci; 2009 Oct; 86(10):E1196-201. PubMed ID: 19741556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Healing of resistant corneal neurotrophic ulcers using a matrix regenerating agent.
    Cochener B; Zagnoli C; Hugny-Larroque C; Derrien S
    J Fr Ophtalmol; 2019 Feb; 42(2):159-165. PubMed ID: 30573293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix Regenerating Agent (RGTA) in a Neurotrophic Corneal Ulcer.
    Pereira S; Resende R; Coelho P; Sampaio F
    Cureus; 2020 Oct; 12(10):e11167. PubMed ID: 33251074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acanthamoeba keratitis in Porto Alegre (southern Brazil): 28 cases and risk factors.
    Dos Santos DL; Kwitko S; Marinho DR; de Araújo BS; Locatelli CI; Rott MB
    Parasitol Res; 2018 Mar; 117(3):747-750. PubMed ID: 29332157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acanthamoeba keratitis: persistent organisms without inflammation after 1 year of topical chlorhexidine.
    Gooi P; Lee-Wing M; Brownstein S; El-Defrawy S; Jackson WB; Mintsioulis G
    Cornea; 2008 Feb; 27(2):246-8. PubMed ID: 18216589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical Treatment of Persistent Epithelial Defects with a Matrix Regenerating Agent.
    Sevik MO; Turhan SA; Toker E
    J Ocul Pharmacol Ther; 2018 Nov; 34(9):621-627. PubMed ID: 30312119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 18S rDNA sequencing aided diagnosis of
    Singh A; Acharya M; Jose N; Gandhi A; Sharma S
    Indian J Ophthalmol; 2019 Nov; 67(11):1886-1888. PubMed ID: 31638063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of miltefosine in the management of refractory Acanthamoeba keratitis.
    Tavassoli S; Buckle M; Tole D; Chiodini P; Darcy K
    Cont Lens Anterior Eye; 2018 Aug; 41(4):400-402. PubMed ID: 29580956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.